Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Analyst Ratings

• Total Analysts: 2
• Consensus Rating: Buy
• Price Target: $29.50
• Upside: +6.92%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $29 → $37	Buy	Maintains	$29 → $37	+34.11%	Mar 14, 2024
George Sellers Stephens & Co.	Stephens & Co.	Hold Reiterates $22	Hold	Reiterates	$22	-20.26%	Mar 14, 2024
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $28 → $29	Buy	Maintains	$28 → $29	+5.11%	Jan 3, 2024
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $24 → $28	Buy	Maintains	$24 → $28	+1.49%	Nov 3, 2023
Michael Petusky Barrington Research	Barrington Research	Hold → Buy Upgrades $24	Hold → Buy	Upgrades	$24	-13.01%	Aug 14, 2023
George Sellers Stephens & Co.	Stephens & Co.	Hold Maintains $28 → $23	Hold	Maintains	$28 → $23	-16.64%	Aug 10, 2023
George Sellers Stephens & Co.	Stephens & Co.	Hold Reiterates $28	Hold	Reiterates	$28	+1.49%	May 31, 2023
George Sellers Stephens & Co.	Stephens & Co.	Hold Reiterates $28	Hold	Reiterates	$28	+1.49%	Apr 14, 2023
Michael Petusky Barrington Research	Barrington Research	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Mar 7, 2023
Michael Petusky Barrington Research	Barrington Research	Hold → Buy Upgrades $31	Hold → Buy	Upgrades	$31	+12.36%	Nov 9, 2022
George Sellers Stephens & Co.	Stephens & Co.	Hold Initiates $26	Hold	Initiates	$26	-5.76%	Oct 14, 2022
Chris Cooley Stephens & Co.	Stephens & Co.	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Mar 9, 2022
Chris Cooley Stephens & Co.	Stephens & Co.	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Nov 16, 2021
Michael Petusky Barrington Research	Barrington Research	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Dec 16, 2020
James Sidoti Sidoti & Co.	Sidoti & Co.	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Jan 21, 2020